ArticleInternational journal of clinical and experimental medicine2015

Polymorphisms of ERCC1 and XRCC1 predict the overall survival of advanced gastric cancer patients receiving oxaliplatin-based chemotherapy.

Lijian Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.